EUVIMEDEUVIMED entdecken
Crossref

Differential mechanism of action of the CK1$\varepsilon $ inhibitor GSD0054

Irene Lagunes, Elva Martín-Batista, Gastón Silveira-Dorta, Miguel X. Fernandes, José M. Padrón

Journal of Molecular and Clinical Medicine · 2018

DOI: 10.31083/j.jmcm.2018.02.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular and Clinical Medicine, 2018. Verfasst von Irene Lagunes und 4 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the current study, we explored for the first time, the mechanism of action of the new Casein kinase 1 $\varepsilon$ (CK1$\varepsilon$) selective inhibitor GSD0054. Although GSD0054 behaved as a selective CK1$\varepsilon $ inhibitor in enzymatic assays, we studied whether this inhibitory activity also occurred inside the cells. The effects of GSD0054 on $\beta $-catenin expression and disruption of cell cycle progression were studied in the human breast cancer cell lines MDA-MB-453 ($\beta $-catenin negative) and T-47D ($\beta $-catenin positive). We also performed molecular modeling studies using computational docking against CK1$\varepsilon $ to explain and predict the mechanism of action of this compound. Moreover, the commercially available CK1$\varepsilon $ inhibitor PF-4800567 and the CK1$\delta $/$\varepsilon $ inhibitors PF-670462 and IC261 were also studied for comparison purposes.GSD0054 showed anti-proliferative activity against MDA-MB-453 and T-47D cells despite the fact that MDA-MB-453 cells do not possess active $\beta$-catenin. However, selective cell killing occurred in the more resistant, $\beta $-catenin active, T-47D cells. CK1$\varepsilon $ was confirmed as a cellular target, although other targets or alternative mechanisms of action could possibly explain the anti-proliferative activity in MDA-MB-453 cells.

Zitieren

APA

Lagunes, I., Martín-Batista, E., Silveira-Dorta, G., Fernandes, M. X., & Padrón, J. M. (2018). Differential mechanism of action of the CK1$\varepsilon $ inhibitor GSD0054. Journal of Molecular and Clinical Medicine. https://doi.org/10.31083/j.jmcm.2018.02.004

Vancouver

Lagunes I, Martín-Batista E, Silveira-Dorta G, Fernandes MX, Padrón JM. Differential mechanism of action of the CK1$\varepsilon $ inhibitor GSD0054. Journal of Molecular and Clinical Medicine. 2018. doi:10.31083/j.jmcm.2018.02.004

BibTeX
@article{Lagunes2018,
  author = {Lagunes, Irene and Martín-Batista, Elva and Silveira-Dorta, Gastón and Fernandes, Miguel X. and Padrón, José M.},
  title = {Differential mechanism of action of the CK1$\varepsilon $ inhibitor GSD0054},
  journal = {Journal of Molecular and Clinical Medicine},
  year = {2018},
  doi = {10.31083/j.jmcm.2018.02.004}
}
Kostenlos starten →